Genengnews -- Oxeco has conditionally agreed to acquire regenerative therapies firm Tissue Regenix for £12 million, or about $17.53 million, in shares. Oxeco, in addition, reported that it has conditionally raised £4.5 million, or approximately $6.57 million, before expenses by way of a placing. It is expected to bolster the newly combined firm’s working capital to about £7.4 million, or roughly $10.81 million) net.
